Eupraxia Pharmaceuticals (TSE:EPRX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Eupraxia Pharmaceuticals is hosting a webinar on November 15, 2024, focusing on Eosinophilic Esophagitis, a rapidly growing digestive disorder. CEO Dr. James A. Helliwell will lead the discussion, highlighting the company’s innovative drug delivery technology aimed at addressing unmet medical needs.
For further insights into TSE:EPRX stock, check out TipRanks’ Stock Analysis page.